Characteristics of the deep grey matter lesions in our population.

<p>Characteristics of the deep grey matter lesions in our population.</p

Cross validation (Jacknife test).

<p>In each validation test, we used data from all but one subject (S -1 of the S subjects) to train the classifier.</p

Baseline characteristics of the study population at inclusion and quality of the liver graft.

<p>Baseline characteristics of the study population at inclusion and quality of the liver graft.</p

DGML semi-quantitative scale.

<p><b>A</b>. No lesion; <b>B</b>. Punctuate lesion; <b>C</b>. Lesion involving less than 1/3^rd of the nucleus. <b>D</b>. Lesion involving between 1/3^rd and 2/3^rd of the nucleus. <b>E</b>. Lesion of more than 2/3^rd of the nucleus. <b>F</b>. Total involvement of the nucleus.</p

Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month - Fig 2

<p><b>(A) Boxplots for platelet count and (B) CD34+ hematopoietic progenitor stem cells at different time points.</b> Horizontal lines show median values and the 25–75 percentiles. Pre LT: pre liver transplantation.</p

Demographic characteristics of patients involved in our study.

<p>Demographic characteristics of patients involved in our study.</p

Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: A prospective exploration over a month - Fig 3

<p><b>Boxplots at different time points for (A) 10 μM ADP-induced platelet aggregation, (B) 1.5 mM arachidonic acid-induced platelet aggregation, (C) 20 μM TRAP-induced platelet aggregation, (D) 1 mg/mL ristocetin-induced platelet agglutination, (E) platelet microvesicles as a % of total platelet count, (F) soluble CD62P.</b> Horizontal lines show median values and the 25–75 percentiles. Pre LT: pre liver transplantation.</p

Baseline and evolution of the biological parameters of the 50 patients with the 3 time-point available data.

<p>Baseline and evolution of the biological parameters of the 50 patients with the 3 time-point available data.</p

Example of a satisfactory registration of the DGM on a T2 FSE axial slice passing through the thalami (delineated in green) and striatum (delineated in blue).

<p>Note the punctuate lesion involving the left thalamus (arrow).</p

Receiver operating characteristic (ROC) curves and area under the curve (AUCs) for the different grading scales used in this studies, alone or in combination, with or without the factor “age” taken into account.

<p>Note that the AUC of the ROC curve of the DGM nuclei grading scale was higher than the one of the other scores, alone or combined, with or without the age.</p